Prognostic Significance and Functional Role of CEP57 in Prostate Cancer-Reference-Cited by-同舟云学术

Prognostic Significance and Functional Role of CEP57 in Prostate Cancer

Published:2015-12 Issue:6 Volume:8 Page:487-496
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Mang Josef,Korzeniewski Nina,Dietrich Dimo,Sailer Verena,Tolstov Yanis,Searcy Sam,von Hardenberg Jost,Perner Sven,Kristiansen Glen,Marx Alexander,Roth Wilfried,Herpel Esther,Grüllich Carsten,Popeneciu Valentin,Pahernik Sascha,Hadaschik Boris,Hohenfellner Markus,Duensing Stefan

Funder

Medical Faculty Heidelberg

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

3. High-risk prostate cancer: a disease of genomic instability;Tapia-Laliena;Urol Oncol,2014

4. A tentative classification of centrosome abnormalities in cancer;Duensing;Cell Biol Int,2005

5. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression;Pihan;Cancer Res,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Functional Yeast-Based Screen Identifies the Host Microtubule Cytoskeleton as a Target of Numerous Chlamydia pneumoniae Proteins;International Journal of Molecular Sciences;2023-04-20

2. Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential;Cancers;2023-04-18

3. Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers;Cancers;2023-03-21

4. Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers;Cancers;2020-11-19

5. FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer;Urologic Oncology: Seminars and Original Investigations;2018-08